Neurally adjusted ventilator assist versus pressure support ventilation for noninvasive ventilation during acute respiratory failure: a cross-over physiological study.
ABSTRACT ABSTRACT BACKGROUND:Patient-ventilator asynchrony is common during noninvasive ventilation (NIV) with pressure support ventilation (PSV). We examined the effect of neurally adjusted ventilator assist (NAVA) delivered through a facemask on synchronization in patients with acute respiratory failure (ARF). METHODS:This was a prospective physiological crossover study of 13 patients with ARF (median PaO(2)/FiO(2) 196 [IQR: 142-225]) given two 30-min trials of NIV with PSV and NAVA in random order. Diaphragm electrical activity (EAdi), neural inspiratory time (Tin), trigger delay, asynchrony index (AI), arterial blood gases (ABGs), and patient discomfort were recorded. RESULTS:There were significantly fewer asynchrony events during NAVA than PSV (10 [IQR: 5-14] events vs. 17 [IQR: 8-24] events, p = 0.017) and the occurrence of severe asynchrony (AI > 10%) was also less under NAVA (p = 0.027). Ineffective efforts and delayed cycling were significantly less with NAVA (p < 0.05 for both). NAVA was also associated with reduced trigger delay (0 [IQR: 0-30] ms vs. 90 [IQR: 30-130] ms, p < 0.001) and inspiratory time in excess (10 [IQR: 0-28] ms vs. 125 [IQR: 20-312] ms, p < 0.001), but Tin was similar under PSV and NAVA. EAdi max was higher during NAVA than PSV (p = 0.017). There were no significant differences in ABGs and patient discomfort under PSV and NAVA. CONCLUSION:In view of specific experimental conditions, our comparison of PSV and NAVA indicated that NAVA significantly reduced severe patient-ventilator asynchrony and resulted in similar improvements in gas exchange during NIV for ARF.Trial registry: ClinicalTrials.gov No. NCT01426178.
- SourceAvailable from: Nicolino Ambrosino[show abstract] [hide abstract]
ABSTRACT: Neurally adjusted ventilatory assist (NAVA) is a mode of ventilation wherein the delivered assistance is proportional to diaphragm electrical activity (EAdi) throughout inspiration. We assessed the physiologic response to varying levels of NAVA and pressure support ventilation (PSV) in 13 tracheostomised patients with prolonged weaning. Each patient randomly underwent 8 trials, at four levels of assistance either in PSV and NAVA. i - high (no dyspnoea and/or distress); iv - low (associated with dyspnoea and/or distress; ii and iii - at ∼75% and ∼25% of the difference between high and low support respectively. We measured tidal volume (VT), peak EAdi, (EAdipeak) and airway pressure, ineffective efforts and breathing pattern variability. With both NAVA and PSV, decreasing assistance resulted in parallel significant increase in EAdipeak associated with a concomitant reduction in VT and minute ventilation in PSV, but not in NAVA. VT variability significantly increased when reducing ventilatory assistance in PSV only, while remained unchanged varying the NAVA level. The ineffective triggering index was not significantly different between the two modes. In patients with prolonged weaning, with the specific settings adopted, compared to PSV, NAVA reduced the risk of over-assistance and overall improved patient-ventilator interaction, while not significantly affecting patient-ventilator synchrony.Respiratory medicine 08/2013; · 2.33 Impact Factor
- [show abstract] [hide abstract]
ABSTRACT: Neurally adjusted ventilatory assist (NAVA) delivers pressure in proportion to diaphragm electrical activity (Eadi). However, each patient responds differently to NAVA levels. This study aims to examine the matching between tidal volume (Vt) and patients' inspiratory demand (Eadi), and to investigate patient-specific response to various NAVA levels in non-invasively ventilated patients. 12 patients were ventilated non-invasively with NAVA using three different NAVA levels. NAVA100 was set according to the manufacturer's recommendation to have similar peak airway pressure as during pressure support. NAVA level was then adjusted +/-50% (NAVA50, NAVA150). Airway pressure, flow and Eadi were recorded for 15 minutes at each NAVA level. The matching of Vt and integral of Eadi ([latin small letter esh]Eadi) were assessed at the different NAVA levels. A metric, Range90, was defined as the 5-95% range of Vt/[latin small letter esh]Eadi ratio to assess matching for each NAVA level. Smaller Range90 values indicated better matching of supply to demand. Patients ventilated at NAVA50 had the lowest Range90 with median 25.6 uVs/ml [Interquartile range (IQR): 15.4-70.4], suggesting that, globally, NAVA50 provided better matching between [latin small letter esh]Eadi and Vt than NAVA100 and NAVA150. However, on a per-patient basis, 4 patients had the lowest Range90 values in NAVA100, 1 patient at NAVA150 and 7 patients at NAVA50. Robust coefficient of variation for [latin small letter esh]Eadi and Vt were not different between NAVA levels. The patient-specific matching between [latin small letter esh]Eadi and Vt was variable, indicating that to obtain the best possible matching, NAVA level setting should be patient specific. The Range90 concept presented to evaluate Vt/[latin small letter esh]Eadi is a physiologic metric that could help in individual titration of NAVA level.BioMedical Engineering OnLine 07/2013; 12(1):61. · 1.61 Impact Factor